Erratum to: TRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of th

  • PDF / 177,031 Bytes
  • 2 Pages / 595.276 x 793.701 pts Page_size
  • 75 Downloads / 168 Views

DOWNLOAD

REPORT


CORRECTION

Open Access

TRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of the same sample in women with and without endometriosis Amelie Fassbender, Peter Simsa, Cleophas M Kyama, Etienne Waelkens, Attila Mihalyi, Christel Meuleman, Olivier Gevaert, Raf Van de Plas, Bart de Moor and Thomas M D’Hooghe1,2,3,4*

Since publication of our article [1], we have realised that we did not include the full data in Table 1 and missed the word (TOF) in the result/discussion section. We have provided here the adapted sentence and another version of the table, including all the information intended.

Results/Discussion “Therefore, we plan to repeat this study in a larger sample size including well defined endometrial samples obtained during menstrual, follicular and secretory phase, to validate the reproducibility of SELDI-TOF MS technology in these samples and to identify the protein

Table 1 The representative molecular weights of the proteins identified in the mRNA Microarray study [Thirteen] [2] Protein

Mass in Da

Osteoglycin (OGN/4969)

33,922

Interleukin-6 signal transducer (IL6ST/3572)

isoform 1 103,537 isoform 2 37,499

Cytochrome P450, Family 2, Subfamily J, polypeptide 2 (CYP2J2/1573)

57,611

Carboxypeptidase E (CPE/1363)

53,151

Fibronectin 1 (FN1/2335)

different isoforms 1. 262,607 2. 71,943 3. 259,198 4. 222,944 5. 243,316 6. 240,477 7. 268,894 8. 252,793 9. 246,670 10. 239,608 11. 262,388 12. 221,274 13. 249,304 14. 249,384

* Correspondence: [email protected] 1 Leuven University Fertility Centre, Department of Obstetrics & Gynaecology, University Hospital Gasthuisberg, Leuven, Belgium Full list of author information is available at the end of the article © 2011 Fassbender et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Fassbender et al. Reproductive Biology and Endocrinology 2011, 9:44 http://www.rbej.com/content/9/1/44

Page 2 of 2

Table 1 The representative molecular weights of the proteins identified in the mRNA Microarray study [Thirteen] [2] (Continued) 15. 272,302 Synuclein, gamma (SNCG/6623)

13,331

BAI1-associated protein 2 (BAIAP2/10458)

different isoforms 1. 60,868 2. 59,014 3. 56,626 4. 57,359 5. 57,445 6. 57,430

Protocadherin 17 (PCDH17/27253)

different isoforms 1. 126,229 2. 96,570

Protein tyrosine phosphatase, receptor type, R (PTPRR/5801)

Alpha 73,834 Da Gamma 46,581Da Delta 51,046Da

peaks observed after proteomic analysis, which are expensive and labour intense requiring High-performance liquid chromatography or high-pressure liquid chromatography (HPLC) and matrix assisted laser desorption ionization Time-of-Flight-Mass Spectrometry (MALDI-TOF/ TOF MS).” Author details 1 Leuven University Fertility Centre, Department of Obstetrics & Gynaecology, University Hosp